Zymeworks Inc. (ZYME)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
37.73+0.15 (+0.40%)
At close: 4:00PM EDT
| Previous close | 37.58 |
| Open | 37.33 |
| Bid | 37.59 x 900 |
| Ask | 39.62 x 900 |
| Day's range | 35.58 - 37.87 |
| 52-week range | 24.82 - 59.03 |
| Volume | 531,456 |
| Avg. volume | 414,598 |
| Market cap | 1.742B |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.80 |
| Earnings date | 03 Aug 2021 - 09 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 55.46 |
- Business Wire
Zymeworks to Present at Jefferies Virtual Healthcare Conference
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that the Company will present at the upcoming Jefferies Virtual Healthcare Conference taking place June 1-4, 2021.
- Business Wire
Zymeworks Announces Election of Directors and Voting Results from Shareholder Meeting
Zymeworks Inc. (NYSE: ZYME), a clinical‑stage biopharmaceutical company developing multifunctional biotherapeutics, is pleased to announce the detailed voting results on the items of business considered at its Annual General Meeting of Shareholders held on May 5, 2021 (the "Meeting").
- Zacks
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates
Zymeworks Inc. (ZYME) delivered earnings and revenue surprises of 14.71% and -90.65%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
© 2021 Verizon Media. All rights reserved.
